Both parties will work to a joint research plan with a focus on mechanisms related to inflammation, neuropharmacology and lung irritancy, over an initial three-year period. The work is to be co-led by AZ’ senior […]
In draft guidelines, the National Institute for Health and Care Excellence notes that treatment options for people whose disease has progressed after platinum-based chemotherapy include docetaxel, paclitaxel or best supportive care, and that evidence from […]
A study by scientists at the UK’s University of East Anglia (UEA) has shown that rheumatoid arthritis drug leflunomide could be used to help treat advanced skin cancer. Performed in mice, the study demonstrated that […]
bluebird bio develops gene and cell therapies to treat severe genetic diseases and T-cell based immunotherapies for cancer. The multi-year agreement involves Merck’s Life Science business sector, which will produce lentiviral vectors for bluebird bio’s […]
The decision comes on the back of data from a Phase III trial funded and conducted by UK group Avillion under a collaborative development agreement with the drugs giant. The BFORE (Bosutinib trial in First […]